GIANNINI, DAIANA
 Distribuzione geografica
Continente #
EU - Europa 71
NA - Nord America 71
AS - Asia 19
AF - Africa 11
SA - Sud America 2
Totale 174
Nazione #
US - Stati Uniti d'America 71
IT - Italia 33
SE - Svezia 12
SG - Singapore 10
BG - Bulgaria 9
DE - Germania 7
CI - Costa d'Avorio 5
IN - India 5
SN - Senegal 4
AR - Argentina 2
BE - Belgio 2
CN - Cina 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
NG - Nigeria 2
PL - Polonia 2
VN - Vietnam 2
IE - Irlanda 1
UA - Ucraina 1
Totale 174
Città #
Pisa 14
New York 10
Sofia 9
Chandler 8
Fairfield 8
Serra 7
Woodbridge 7
Abidjan 5
Florence 5
Frankfurt am Main 5
Wilmington 5
Ashburn 4
Dakar 4
Singapore 4
Pune 3
Brussels 2
Buenos Aires 2
Castano Primo 2
Houston 2
Hyderabad 2
Lagos 2
Lawrence 2
London 2
Medford 2
Olomouc 2
Princeton 2
Turin 2
Warsaw 2
Ann Arbor 1
Beijing 1
Bremen 1
Dong Ket 1
Dublin 1
Livorno 1
Ogden 1
Redwood City 1
Seattle 1
Torino 1
Totale 134
Nome #
Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(®)) in immunodeficiency diseases: real-life data from a monocentric experience 45
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 44
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 41
Allergy Workup in the Diagnosis of COVID-19 Vaccines-Induced Hypersensitivity Reactions and Its Impact on Vaccination 35
Efficacy and safety of omalizumab therapy in urticaria vasculitis 23
Totale 188
Categoria #
all - tutte 763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 4 1 2 4 1 4 0 2 2
2021/202243 1 0 3 0 7 12 1 3 2 7 3 4
2022/202350 5 5 1 2 4 8 1 1 16 0 7 0
2023/202471 2 5 6 16 9 15 2 1 2 2 1 10
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 188